Charles H. Abdalian
Nessuna posizione attualmente
Profilo
Charles H.
Abdalian worked as a Chief Financial Officer and Senior Vice President at Coley Pharmaceutical Group, Inc. from 2004 to 2011.
He also worked as a CFO, Treasurer, and Head-Investor Relations at BG Medicine, Inc. in 2013.
Abdalian was the President of Pelias Technologies, Inc. from 2001 to 2002.
He worked as a Principal at Coopers & Lybrand LLP.
Abdalian also worked as a CFO, SVP, and Head-Investor Relations at Molecular Insight Pharmaceuticals, Inc. in 2010.
He started his career as a Chief Financial Officer at Emisphere Technologies, Inc. from 1999 to 2001.
Abdalian holds an MBA from the University of Pennsylvania and an undergraduate degree from Norwich University.
Precedenti posizioni note di Charles H. Abdalian
| Società | Posizione | Fine |
|---|---|---|
| BG MEDICINE, INC. | Direttore Finanziario/CFO | 03/11/2013 |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Direttore Finanziario/CFO | 03/05/2011 |
Pelias Technologies, Inc.
 Pelias Technologies, Inc. Pharmaceuticals: GenericHealth Technology Pelias Technologies, Inc. develops long term sustained release drug encapsulation and delivery systems. The company was founded in 1997 and is headquartered in Cambridge, MA. | Presidente | 01/12/2002 |
| EMISPHERE TECHNOLOGIES, INC. | Direttore Finanziario/CFO | 01/07/2001 |
Tafkak, Inc.
 Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA. | Direttore Finanziario/CFO | - |
Formazione di Charles H. Abdalian
| University of Pennsylvania | Masters Business Admin |
| Norwich University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BG MEDICINE, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Tafkak, Inc.
Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA. | Commercial Services |
| Coopers & Lybrand LLP | Commercial Services |
Pelias Technologies, Inc.
Pelias Technologies, Inc. Pharmaceuticals: GenericHealth Technology Pelias Technologies, Inc. develops long term sustained release drug encapsulation and delivery systems. The company was founded in 1997 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Charles H. Abdalian
